Genovel Orthopedics, NYU Sign Agreement to Develop Knee Osteoarthritis Treatment Technology

 

Genovel Orthopedics has signed a research and license agreement with New York University for the development and commercialization of a new technology for osteoarthritis of the knee.

Advertisement

The technology — designed by Peter S. Walker, PhD, professor, department of orthopedic surgery, department of mechanical and aerospace engineering, NYU-Polytechnic; and Joseph Bosco, MD, associate professor, vice chair for clinical affairs, department of orthopedic surgery at NYU School of Medicine — is a next-generation treatment for patients who suffer from osteoarthritis of the knee.

 

Genovel Orthopedics is a company founded by Pansend, a wholly owned subsidiary of HC2 Holdings.

More Articles on Orthopedics:

University of Rochester Medical Center Receives 750k Gift for Orthopedic Research
Dr. James Andrews Performs Elbow Surgery on Pittsburgh Pirate Kyle McPherson
Dr. Tariq Hussain Joins UHS Orthopedics-Norwich

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.